Crossover reaction between haloperidol and amoxapine for NMS

Koichi Otani; Kazuo Mihara; Motohiro Okada; Sunao Kaneko; Yutaka Fukushima

doi:10.1192/bjp.159.6.889

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

References

Baca, L. & Martinelli, L. (1990) Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant. Neurology, 40, 1797–1798.CrossRef Google Scholar PubMed

Cohen, B. M., Harris, P. Q., Altesman, R. I., et al (1982) Amoxapine: neuroleptic as well as antidepressant? American Journal of Psychiatry, 139, 1165–1167.Google Scholar PubMed

Halman, M. & Goldbloom, D. S. (1990) Fluoxetine and neuroleptic malignant syndrome. Biological Psychiatry, 28, 518–521.CrossRef Google Scholar PubMed

Otani, K., Horiuchi, M., KoNDO, T., et al (1991) is the predisposition to neuroleptic malignant syndrome genetically transmitted? British Journal of Psychiatry, 158, 850–853.CrossRef Google Scholar PubMed

Rosebush, P. & Stewart, T. (1989) A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 717–725.Google Scholar

Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Otani, K. Mihara, K. Kondo, T. Okada, M. Kaneko, S. and Fukushima, Y. 1992. Treatment of neuroleptic malignant syndrome with levodopa. Human Psychopharmacology: Clinical and Experimental, Vol. 7, Issue. 3, p. 217.

&NA; 1992. Amoxapine/haloperidol. Reactions Weekly, Vol. &NA;, Issue. 383, p. 5.

Tanaka, Osamu Otani, Koichi Kondo, Tsuyoshi Kaneko, Sunao and Fukushima, Yutaka 1993. Paralytic ileus as a prodromal symptom of the neuroleptic malignant syndrome. Human Psychopharmacology: Clinical and Experimental, Vol. 8, Issue. 5, p. 367.

Young, A.H. and Cowen, P.J. 1993. Vol. 17, Issue. , p. 16.

CrossRef

Mancias, Pedro Kramer, Larry and Butler, Ian J. 1995. Amoxapine Overdose in a Young Man: A Transient Mitochondrial Abnormality?. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Vol. 15, Issue. 4, p. 528.

Ishida, M. Otani, K. Kaneko, S. Ishida, H. and Kawashima, S. 1996. Hyperglycemia as a symptom of neuroleptic malignant syndrome. Human Psychopharmacology: Clinical and Experimental, Vol. 11, Issue. 2, p. 137.

Gill, Harry S. DeVane, C. Lindsay and Risch, S. Craig 1997. Extrapyramidal Symptoms Associated With Cyclic Antidepressant Treatment. Journal of Clinical Psychopharmacology, Vol. 17, Issue. 5, p. 377.

Okada, Motohiro Wada, Kazumaru Kiryu, Kazuhiro Kawata, Yuko Mizuno, Kazuhisa Kondo, Tuyoshi Tasaki, Hiroichi and Kaneko, Sunao 1998. Effects of Ca2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis. British Journal of Pharmacology, Vol. 123, Issue. 5, p. 805.

Suzuki, Akihito Kondo, Tsuyoshi Otani, Koichi Mihara, Kazuo Yasui-Furukori, Norio Sano, Akira Koshiro, Kazuko and Kaneko, Sunao 2001. Association of the TaqI A Polymorphism of the Dopamine D2 Receptor Gene With Predisposition to Neuroleptic Malignant Syndrome. American Journal of Psychiatry, Vol. 158, Issue. 10, p. 1714.

Hayashi, Hiroshi Kawakatsu, Shinobu Watanabe, Kyota Fukasawa, Takashi and Otani, Koichi 2002. Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 26, Issue. 6, p. 1225.

Mihara, Kazuo Kondo, Tsuyoshi Yasui-Furukori, Norio Ono, Shingo Kaneko, Sunao and Otani, Koichi 2002. Dopamine D2 receptor gene polymorphisms and clinical response to selective dopamine receptor antagonists. International Congress Series, Vol. 1244, Issue. , p. 77.

Mihara, Kazuo Kondo, Tsuyoshi Suzuki, Akihito Yasui‐Furukori, Norio Ono, Shingo Sano, Akira Koshiro, Kazuko Otani, Koichi and Kaneko, Sunao 2003. Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Vol. 117B, Issue. 1, p. 57.

Zhu, Gang Okada, Motohiro Yoshida, Shukuko Hirose, Shinichi and Kaneko, Sunao 2004. Both 3,4-dihydroxyphenylalanine and dopamine releases are regulated by Ca2+-induced Ca2+ releasing system in rat striatum. Neuroscience Letters, Vol. 362, Issue. 3, p. 244.

Zhu, Gang Okada, Motohiro Yoshida, Shukuko Hirose, Shinichi and Kaneko, Sunao 2004. Determination of exocytosis mechanisms of DOPA in rat striatum using in vivo microdialysis. Neuroscience Letters, Vol. 367, Issue. 2, p. 241.

Bhanushali, Minal J and Tuite, Paul J 2004. The evaluation and management of patients with neuroleptic malignant syndrome. Neurologic Clinics, Vol. 22, Issue. 2, p. 389.

Higashi, Yasuhiko Nakamura, Shota and Fujii, Youichi 2006. Sensitive determination of 4‐(4‐chlorophenyl)‐4‐hydroxypiperidine, a metabolite of haloperidol, in a rat biological sample by HPLC with fluorescence detection after pre‐column derivatization using 4‐fluoro‐7‐nitro‐2,1,3‐benzoxadiazole. Biomedical Chromatography, Vol. 20, Issue. 9, p. 964.

Otani, Koichi Hayashi, Hiroshi Suzuki, Akihito and Aoshima, Toshiaki 2006. Malignant catatonia and neuroleptic malignant syndrome: Revisited. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 30, Issue. 6, p. 1184.

2016. Meyler's Side Effects of Drugs. p. 306.

Article contents

Crossover reaction between haloperidol and amoxapine for NMS

Abstract

References

eLetters

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Article contents

Crossover reaction between haloperidol and amoxapine for NMS

Abstract

References

eLetters

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests